Chetan Huded, MD
Interventional Cardiology · Kansas City, MONPI 1376839894
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (46.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Boston Scientific accounts for 64.8% of it on its own, with 18 other manufacturers making up the rest. 2025 is the largest year on record at $37,955, more than ten times the $1,995 reported in 2019.
Across 253 payments — averaging $241.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$40K
- Edwards Lifesciences$11K
- Medtronic$5K
- Abbott$4K
- Shockwave Medical, Inc$424
- AstraZeneca$159
- plus $389 from 13 others
Across 83 payments — averaging $5465.33 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Boston Scientific$415K
- Medtronic$23K
- Abbott$16K
What the payments were for
- Consulting fees$28,10646%
- Speaking & faculty fees$9,06315%
- Travel & lodging$11,17418%
- Food & beverage$12,55421%
- Education$1200%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 91 | $39,529 |
| Edwards Lifesciences | 45 | $11,127 |
| Medtronic(2 entities) | 42 | $4,905 |
| Abbott | 53 | $4,482 |
| Shockwave Medical, Inc | 4 | $424 |
| AstraZeneca | 3 | $159 |
| Philips North America LLC | 1 | $150 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 2 | $32 |
| Penumbra, Inc. | 2 | $30 |
| Terumo Medical Corporation | 1 | $23 |
| W. L. Gore & Associates, Inc. | 1 | $22 |
| CSL Behring | 1 | $20 |
| Asahi Intecc USA, Inc. | 1 | $20 |
| Merit Medical Systems Inc | 1 | $18 |
| Opsens Inc. | 1 | $18 |
| Livanova USA, Inc. | 1 | $16 |
| Siemens Medical Solutions USA, Inc. | 1 | $16 |
| Abiomed | 1 | $13 |
| Corindus Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WATCHMAN FLX$16,456
- WATCHMAN Access System$11,584
- Watchman$9,430
- Edwards SAPIEN 3 Transcatheter Heart Valve$7,552
- CoreValve Evolut$1,814
- EVOQUE$1,457
- COREVALVE EVOLUT R$1,181
- Omnilink Elite vascular stent system$1,160
- AMPLATZER AMULET$541
- RESOLUTE ONYX$359
- MitraClip$358
- SAPIEN 3 Ultra RESILIA$339
- PASCAL$236
- Shockwave IVL System with the Shockwave C2 Coronary IVL Catheter$194
- NAVITOR$176
- Edwards SAPIEN 3 Ultra Transcatheter Heart Valve$158
- Mitra Clip system$151
- (AO0) IGT Devices Intracardiac$150
- Resolute$145
- OPTICROSS$143
How this compares
$61,017 in reported general payments places this provider in the 85th percentile of 182 interventional cardiology providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 99 | $93,006 |
| JardianceEmpagliflozin | 31 | $32,670 |
| EntrestoSacubitril/Valsartan | 22 | $22,054 |
| Repatha SureclickEvolocumab | 16 | $13,409 |
| Metoprolol Succinate | 103 | $1,674 |
| Rosuvastatin Calcium | 35 | $666 |
| Atorvastatin Calcium | 100 | $613 |
| ClopidogrelClopidogrel Bisulfate | 57 | $543 |
| Warfarin Sodium | 47 | $523 |
| Losartan Potassium | 55 | $408 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 16 | $405 |
| Potassium Chloride | 11 | $364 |
| Furosemide | 65 | $308 |
| Carvedilol | 40 | $248 |
| Amlodipine Besylate | 46 | $247 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Kansas City
- Gerald MancusoKansas City$402K
- James GranthamKansas City$357K
- Matthew BunteKansas City$242K
- Adnan ChhatriwallaKansas City$114K
- Kenneth HuberKansas City$110K
- Adam SalisburyKansas City$52K
- Steven MarsoKansas City$42K
- Dany JacobKansas City$35K
- Muhammad Anis HaiderKansas City$35K
- Francisco LammogliaKansas City$22K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.